Daily Stock Setups

Institute for OneWorld Health Announces New Chief Financial Officer

Posted on: Tue, 04 Aug 2009 06:00:00 EDT

Symbols: TTP

Do you know when to trade TTP ?

Check for a PowerRating from TradingMarkets

SAN FRANCISCO, Aug 04, 2009 (BUSINESS WIRE) --
TTP | Quote | Chart | News | PowerRating -- The Institute for OneWorld Health, the US-based non-profit
pharmaceutical company that develops drugs for people with neglected
infectious diseases in the developing world, today announced the
appointment of Robert E. Farrell, J.D. as its Chief Financial Officer.

Prior to joining OneWorld Health, Farrell served as President and Chief
Financial Officer of Titan Pharmaceuticals, Inc., a biopharmaceutical
company that develops proprietary therapeutics for the treatment of
central nervous system disorders, cardiovascular disease and bone
disease. He also served as Titan's Executive Vice President and Chief
Financial Officer from 1996 to 2008.

"We are delighted to welcome such a highly experienced CFO to OneWorld
Health's leadership team," said Dr. Richard Chin, M.D., OneWorld
Health's Chief Executive Officer. "Bob's extensive biotechnology and
finance experience will make a tremendous contribution to our work at
this pivotal time."

Previously, Mr. Farrell held senior positions at dialysis services
provider Fresenius USA, Inc. from 1991 until August 1996, where he
served as Corporate Group Vice President, Vice President Administration,
Chief Financial Officer and General Counsel.

"This is an exciting and dynamic time to join OneWorld Health and I look
forward to helping advance its mission of developing safe, effective and
affordable drugs to combat infectious diseases and save lives in the
world's most impoverished communities," said Mr. Farrell.

Mr. Farrell has also served as Vice President, Marketing and President
of TXL Securities at Genstar Corporation, as Associate General Counsel
at Brae Corporation and as an associate attorney at Crane & Hawkins. He
holds a B.A. from the University of Notre Dame and a J.D. from Hastings
College of Law, University of California.

About the Institute for OneWorld Health

The Institute for OneWorld Health, the first US nonprofit pharmaceutical
company, develops safe, effective and affordable medicines for people
with neglected diseases of the developing world. The Institute for
OneWorld Health, headquartered in San Francisco, California, USA, is a
tax-exempt 501 (c) (3) US corporation. (http://www.oneworldhealth.org/).
Media resources are available at http://www.oneworldhealth.org/media_center.

SOURCE: Institute for OneWorld Health


Institute for OneWorld Health 
Deborah Schneider, 1-415-277-6973 
dschneider@prandcompany.com

For full details on (TTP) TTP. (TTP) has Short Term PowerRatings at TradingMarkets. Details on (TTP) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.